Blue Cell Therapeutics ApS: Financial statements 2021
CVR: 39981610
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Blue Cell Therapeutics ApS (CVR 39981610) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -843,696 and a net result of DKK -14,241,408 compared with DKK -14,026,899 the year before. Equity in the 2021 report amounted to DKK 12,481,214. The solvency ratio was 89.1%. The company had 7 employees in the financial year.
- Gross Profit
- DKK -843,696
- Profit/Loss
- DKK -14,241,408
- Equity
- DKK 12,481,214
- Total Assets
- DKK 14,004,741
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -844K | -14.2M | 12.5M | 7 |
| 2020 | - | -2.9M | -14M | 9.8M | 2 |
Official annual report
Find more companies like Blue Cell Therapeutics ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Blue Cell Therapeutics ApS has published its annual report for 2020. Gross profit came to DKK -2,943,601, and the net result was DKK -14,026,899.
As of July 8, 2021, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Blue Cell Therapeutics ApS.
As of June 23, 2021, Casper Tind Hansen has joined the board of directors of Blue Cell Therapeutics ApS.
As of June 23, 2021, Ole Vahlgren has joined the board of directors of Blue Cell Therapeutics ApS.
About Blue Cell Therapeutics ApS
Blue Cell Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Regenerative Therapeutics IVS. The management consists of Søren Paludan Sheikh. The board consists of Olav Hellebø (chair), Anella Rogaczewski, Michael Ulveman and Ole Vahlgren. The company is owned by ANDRÉ ROGACZEWSKI HOLDING II ApS and SPSheikh Holding ApS. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -5,780,568 and a net result of DKK -21,221,120 compared with DKK -15,189,850 the year before. Equity in the 2025 report amounted to DKK -8,126,690.